FOXP3 and cancer: The population of these cells in cancer outnumbers the cells with a CD4+CD25+Foxp3+ phenotype, they have the ability to release immunosuppressants such as IL10 and TGF-β1, and the number of these cells increases progressively in HCC along with the stage of the disease [195].